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Definitions and forms of primary, genetic HCM 
Hypertrophic cardiomyopathy (HCM) is a clinical heterogeneous cardiac disease that is in 
most cases inherited as an autosomal dominant trait. According to the classification of the 
American Heart Association (AHA), HCM is a primary genetic heart disease. HCM is 
morphologically characterized and defined as a hypertrophied, non-dilated left ventricle (LV) 
without any underlying systemic or cardiac disease that could cause LV hypertrophy (LVH), 
like systemic hypertension or (sub-)aortic stenosis. HCM is usually a progressive disease that 
finally leads to congestive heart failure (CHF) or sudden death, however, the degree of 
hypertrophy and the velocity of the progression is highly variable with some affected 
individuals dying very young, and others remaining in a compensated state until old age.  
Diagnosis is usually based upon two-dimensional (2D) echocardiography. 
In humans and cats the echocardiographic picture is very heterogeneous concerning the 
severity of LVH and myocardial hyperechogenicity as well as the localisation of LVH. The 
hypertrophy may be symmetrical (global) and assymetrical (regional). The symmetric form 
affects the LV homogenously, whereas the asymmetric form involves selectively only the 
papillary muscles, the LV posterior wall, the interventricular septum (IVS) as a whole or only 
focally just below the aortic valve. Systolic anterior motion of the mitral valve (SAM) is 
common in HCM, and for this dynamic subaortic stenosis the term hypertrophic obstructive 
cardiomyopathy (HOCM) was created. Secondary obstruction of the LV outflow tract 
(LVOT) may worsen LV hypertrophy through additional pressure overload.  
 
 
HCM  SAM; SAM = HCM ? 
The development of SAM has commonly been attributed to LVH, narrowing of the LVOT 
and drag forces acting on the anterior mitral valve leaflet, i.e. SAM has been considered a 
complication or consequence of HCM. However, in some cats with SAM it has been observed 
that both SAM and LVH disappeared under treatment with betablockers. Furthermore SAM 
may be observed in very young or quite old cats without any LVH, when echocardiography is 
performed to detect the source of a (new) murmur. These observations imply that SAM may 
be a primary problem that may cause secondary LV hypertrophy. A similar albeit rare 
phenomenon has been described in dogs by D’Agnolo and others. The question arises 
concerning the development and the classification of this entity; experimentally, SAM can be 
produced by displacement of the anterior papillary muscle. Possibly, the cause of "primary 
 SAM" is different in young, and in older cats. In young cats a congenital abnormality of the 
anterior papillary muscle resulting in an abnormal attachment of the chordae tendineae and 
mitral valve may be the cause; this entity probably should be classified as mitral valve 
dysplasia. In older cats with a new heart murmur and "primary SAM", myocardial and 
especially papillary muscle remodeling  secondary to inflammatory, toxic, or ischemic insults 
may responsible. These entities should rather be classified as secondary cardiomyopathies.    
 
Myokarditis versus HCM 
Myocarditis is known to cause abnormal myocardial function and cardiac dilation in humans 
for many years. Many cases of dilated cardiomyopathy (DCM) are actually caused by 
myocarditis. In humans, myocarditis is therefore classified as primary mixed cardiomyopathy. 
Myocarditis in cats is also well recognized. Interestingly, in affected cats echocardiography 
usually often does not show DCM but LVH. In a recent pathological study, cats with 
cardiomyopathy were examined by histology and by PCR. 55 % of the cats with HCM 
showed signs of active myocarditis on histology, and parvovirus was found in some. The 
authors have examined several cats that had developed pulmonary oedema associated with 
anaesthesia or surgery, and that on echocardiography had shown LVH and left atrial dilation 
typical of HCM. Supportive therapy including diuretics and oxygen led to resolution of the 
congestion and clinical normalisation. Repeated echocardiography showed a successive 
regression of LVH and LA dilation. This presentation and disease course argue against 
primary HCM, but rather for a reversible damage like infectious or toxic myocarditis.   
 
Steroid-induced „HCM“ 
A similar picture as in the suspected myocarditis cases with acute congestive heart failure has 
been reported in cats after the application of steroids. Such cats, initially diagnosed with HCM 
due to LV hypertrophy and LA dilation did not only recover clinically from congestive heart 
failure but did also normalize echocardiographically. Nevertheless, attempts to elicit this form 
of cardiomyopathy experimentally were unsuccessful. The question arises, if a genetic 
predisposition is required to react in this fashion to steroids, or alternatively if affected cats in 
fact had myocarditis associated with glucocorticoid application. 
 
Hyperthyroidism-induced cardiomyopathy 
Thyroid hormones have important metabolic and cardiovascular effects. Hyperthyroidism 
causes an increased metabolic rate which demands an increased cardiac output. In the 
periphery thyroid hormones cause a decreased vascular resistance. In the myocardium, thyroid 
hormones induce multiple genes causing LV hypertrophy. Echocardiographically, these 
 pathophysiological changes are expected to be reflected by LV volume overload, respectively 
eccentric LVH. However, concentric hypertrophy secondary to hyperthyroidism has been 
reported as well  
 
Myocardial hypertrophy caused by infiltrations 
Infiltrative myocardial diseases like amyloidosis have not been reported in veterinary 
medicine. Rarely, diffuse neoplastic infiltrations are found in malignant lymphoma that on 
echocardiography look similar to LVH, respectively HCM.  
 
HCM as cause of systemic hypertension (?) 
Occasionally, HCM has been reported as differential diagnosis for systemic hypertension. 
However, as blood pressure is a function of cardiac output and peripheral resistance, there is 
no rational explanation for such a relationship. LVH with or without CHF associated with 
truly elevated blood pressure has to be considered consequence and not cause of the 
hypertension. Likewise, if LVH is found echocardiographically and HCM suspected, systemic 
hypertension should be ruled out before HCM is diagnosed. 
 
Pseudohypertrophy 
Like with any hollow organ in the body, the wall thickness of the heart physiologically 
changes as a function of its filling, e.g. the wall is thinner in diastole and thicker in systole. 
Similarly, with (iatrogenic) hypervolemia there will be an increase in ventricular and atrial 
size and decrease in wall thickness, with dehydration cardiac size will decrease and wall 
thickness will increase.  
 
When HCM looks like DCM - the "burn out" cardiomyopathy 
In some case of feline (and human) HCM a regression of the LV hypertrophy can be seen 
during disease progression. The myocardial wall gets thinner, the LV volume becomes 
overloaded and progressive systolic dysfunction develops. It may be difficult to differentiate 
this echocardiographic picture from DCM, unless the patient has been examined and 
diagnosed at previous examinations with HCM. This presentation is considered end stage 
HCM and is called "burn out" cardiomyopathy.  
 
Synopsis 
Based on the above explanations, the following aspects should be considered when 
echocardiographically LVH is found, and before HCM is diagnosed: 
- Is the LVH only a pseudohypertrophy secondary to hypovolemia? 
 -
 
Is a fixed or dynamic (sub-) aortic stenosis present?  
- Is systemic hypertension present?  
- Did the cat receive steroids, is there a history of recent anaesthesia, or is systemic, 
potentially bacterial, disease present?  
- Does the cat have hyperthyroidism? 
If any of these questions is answered with "yes", treatment should be started according to the 
underlying disease. If on follow-up examinations echocardiographic changes are reversible, 
the cat does not have primary HCM.  
To summarize, several myocardial diseases can look like HCM on echocardiography. Only 
clinical and echocardiographic follow-up examinations allow the differentiation between 
primary HCM and secondary left ventricular wall thickening. Various diseases looking like 
HCM but which are curable should be considered and treated accordingly, before a cat with 
congestive heart failure is diagnosed with HCM, a genetic, progressive, non-curable, and 
ultimately fatal heart disease.  
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